About Contact Us Careers

Q Fever Market Trends

Request Free Sample Copy

Report ID: 4118
Published Date: Aug 13, 2024
Report Format: PDF, PPT

Buy Now

Q Fever Market Trends

Growth Drivers

Escalating Patient Pool Due to Higher Prevalence of Q Fever
Increasing Demand for Enhanced Diagnostic Solutions
Growing Awareness of Acute & Chronic Q Fever Prevention

Challenges

Lack of Requisite Medical Treatment of the Disease

Q Fever Market: Key Insights

Base Year	2023
Forecast Year	2024–2036
CAGR	5.1%
Base Year Market Size (2023)	USD 527.4 million
Forecast Year Market Size (2036)	USD 1 billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Q Fever Market Size & Share, Forecast Report 2036

Author Credits: Radhika Pawar

Report ID: 4118
Published Date: Aug 13, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of Q fever is assessed at USD 548.92 million.

Q Fever Market size was valued at USD 527.4 million in 2023 and is likely to reach USD 1 billion by 2036, registering around 5.1% CAGR during the forecast period i.e., between 2024-2036. Growing patient pool on account of the higher prevalence of Q fever, rising demand for enhanced diagnostic solutions, and increasing awareness of acute & chronic Q fever prevention will propel the market growth.

North America industry is estimated to account for largest revenue share by 2036, due to increasing awareness of infectious diseases, growing demand for enhanced diagnostic facilities, and a higher prevalence of Q fever in the region.

The major players in the market are Pfizer Inc., Arix Bioscience plc, Yashica Pharmaceuticals Pvt. Ltd, Merck KGaA, Melinta Therapeutics LLC, Teva Pharmaceutical Ltd., Bayer AG, and Johnson & Johnson Services, Inc.

Inquiry Before Buying Request Free Sample